The deal range was $2.85-$2.95. Leerink, Stifel and Guggenheim acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XFOR:
- X4 Pharmaceuticals announces common stock offering, no amount given
- Altimmune appoints Christophe Arbet-Engels as CMO
- X4 Pharmaceuticals Announces Major Strategic Restructuring
- X4 Pharmaceuticals announces restructuring, 50% reduction in workforce
- X4 Pharmaceuticals files to sell 59.89M shares of common stock for holders